Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity
Nowadays, leishmaniasis is still treated with outdated drugs that present several obstacles related to their high toxicity, long duration, parenteral administration, high costs and drug resistance. Therefore, there is an urgent demand for safer and more effective novel drugs. Previous studies indica...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | info:eu-repo/semantics/article |
| Language: | eng |
| Published: |
Elsevier
2023
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10171/67681 |